Information Provided By:
Fly News Breaks for July 12, 2018
LOXO
Jul 12, 2018 | 07:32 EDT
Oppenheimer analyst Leah Rush Cann raised her price target for Loxo Oncology to $202 from $122 to account for an increased average forward price-to-sales multiple of the biotechnology sector. The analyst reiterates an Outperform rating on the shares.
News For LOXO From the Last 2 Days
There are no results for your query LOXO